Papers by Boyoung Joung
Page 1 · newest first
- A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian SubjectsCHEST Journal · 2018
- Extended Outcomes of the ADAPT AF-DES TrialNew England Journal of Medicine · 2026
- Subcutaneous Defibrillator for Primary Prevention in Chronic Kidney Disease Stage 3–5: The Single‐Arm STEADIED StudyPacing and Clinical Electrophysiology · 2026
- The Europe–Asia-Pacific Divide in Atrial Fibrillation Management: Evidence, Practice, and PolicyJACC Asia · 2026
- Day–Night Patterns of Wearable-Derived Electrocardiographic Age and Left Atrial Remodeling in Atrial Fibrillation–Naïve IndividualsHeart Rhythm · 2026
- 2026 Asia Pacific Heart Rhythm Society ( APHRS ) Guidelines (Part IV ) on Comprehensive Lifestyle Risk Factor and Comorbidity Management in Atrial FibrillationJournal of Arrhythmia · 2026
- 2026 Asia Pacific Heart Rhythm Society ( APHRS ) Guidelines (Part II ) on Stroke Prevention in Atrial FibrillationJournal of Arrhythmia · 2026
- 2026 Asia Pacific Heart Rhythm Society ( APHRS ) Guidelines (Part I) on Epidemiology, Detection/Screening and Integrated Patient Care in Atrial FibrillationJournal of Arrhythmia · 2026
- 2026 Asia Pacific Heart Rhythm Society ( APHRS ) Guidelines (Part III ) on Rate and Rhythm Control in Atrial FibrillationJournal of Arrhythmia · 2026
- Electroanatomic Remodeling of the Left Stellate Ganglion After Myocardial InfarctionJournal of the American College of Cardiology · 2012
- Initial Experience With Pulsed Field Ablation in Korea: Procedural and Clinical Perspectives From the High-Volume, First-Year Experience at a Single CenterSunhwan'gi · 2026
- Stroke Risk-Based Anticoagulation After Atrial Fibrillation Ablation: ALONE-AF Post-Hoc AnalysisHeart Rhythm · 2026
- Association of angiotensin receptor-neprilysin inhibitor duration with latent remodeling following implantable cardioverter defibrillator implantationHeart Rhythm · 2026
- Rationale and design of a multicenter randomized trial of adjunctive non-pulmonary vein trigger ablation in persistent atrial fibrillation: The EXPORT trialAmerican Heart Journal · 2026
- Prediction of Atrial Fibrillation Risk Through the Integration of Genetic Information and Artificial Intelligence‐Based Electrocardiogram DataJournal of Arrhythmia · 2026
- Virtual Heart–Based Prediction of Ablation Outcomes in Persistent Atrial Fibrillation Based on Non–Pulmonary Vein DriversCirculation Arrhythmia and Electrophysiology · 2026
- Anticoagulation for Atrial Fibrillation with Intermediate Stroke RiskNew England Journal of Medicine · 2026
- Korean atrial fibrillation network genome-wide association study for early-onset atrial fibrillation identifies novel susceptibility lociEuropean Heart Journal · 2017
- Long-Acting Factor XI Inhibition and Periprocedural BleedingJournal of the American College of Cardiology · 2025
- Magnetically guided apoptotic mesenchymal stem cell-derived nanovesicles for the modulation of pathological remodeling in cardiac injuryActa Biomaterialia · 2026
- Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohortEuropean Heart Journal · 2019
- Lean Body Mass is the Independent and Predominant Anthropometric Variable Associated With Atrioventricular BlockHeart Rhythm O2 · 2026
- Effects of atrial fibrillation catheter ablation vs medical therapy on cognitive function and psychological distress: a randomized clinical trialEuropean Heart Journal · 2025
- The optimal lookback period for estimating atrial fibrillation incidence, prevalence, and cardiovascular outcome: nationwide AF registryEuropean Heart Journal · 2025
- Magnetic nanovesicle-mediated mRNA delivery targets injured cardiac tissue and rescues ischemic injury with low immunogenicityEuropean Heart Journal · 2025
- Renal function and factor XI inhibition in atrial fibrillation: a pre-specified analysis of AZALEA-TIMI 71European Heart Journal · 2025
- Prior anticoagulation experience, bleeding risk, and safety of factor XI inhibition in atrial fibrillation: an analysis of AZALEA-TIMI 71European Heart Journal · 2025
- How does artificial intelligence-derived electrocardiographic age and sex predict recurrence outcomes after atrial fibrillation catheter ablation?European Heart Journal · 2025
- Efficacy and safety of direct oral anticoagulants for intermediate stroke risk in patients with atrial fibrillation (SINGLE-AF): Study design and protocolHeart Rhythm O2 · 2025
- Safety and Clinical Outcome of Subcutaneous Implantable Cardioverter‐Defibrillators in an Asian Population: A Prospective StudyJournal of Cardiovascular Electrophysiology · 2025
- Asia Pacific Heart Rhythm Society (APHRS) scientific statement on stroke prevention strategies in patients with device-detected atrial fibrillation: the 4S-DDAF approachThe Lancet Regional Health - Western Pacific · 2025
- Association between non-ablated left atrial surface area and rhythm outcome in patients treated with cryoballoon and radiofrequency ablationHeart Rhythm O2 · 2025
- Therapy for Atrial Fibrillation in Patients with Drug-Eluting StentsNew England Journal of Medicine · 2025
- Sarcopenia in atrial fibrillation: a risk factor for adverse outcomes in a UK Biobank studyEP Europace · 2025
- Mapping and ablation outcomes of extra-pulmonary vein triggers in atrial fibrillation: Single-center retrospective study with consistent provocation protocol.2025
- Dynamic changes of artificial intelligence estimated electrocardiographic age and sex predicts recurrence after atrial fibrillation catheter ablationEP Europace · 2025
- Safety and efficacy of an intrinsic antitachycardia pacing algorithm in patients from Japan and South Korea: results from a cardiac device registry in the Asia Pacific regionJournal of Medical Economics · 2025
- Recent-onset atrial fibrillation: challenges and opportunitiesEuropean Heart Journal · 2025
- Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial FibrillationJAMA · 2025
- Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney FunctionJAMA Cardiology · 2025
- Enhanced Therapeutic potential of AEBP1 silencing via engineered Apoptotic Mesenchymal Stem Cell- derived Nanovesicles in Atrial Fibrillation2025
- Effects of Right and Left Ventricular Pacing for Substrate Mapping Using Decrement-Evoked Potential Mapping in Patients with Scar-Related Ventricular Tachycardia2025
- Temporal trends in ischemic stroke and female sex as a risk modifier in atrial fibrillation: insights from non-anticoagulated Asian patients in a nationwide cohort studySHILAP Revista de lepidopterología · 2025
- Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 TrialCirculation · 2025
- Optimizing outcomes: adherence to the ABC (Atrial fibrillation Better Care) pathway in Asian atrial fibrillation patients with chronic kidney diseaseThe Lancet Regional Health - Western Pacific · 2025
- Proteomic Signatures for Risk Prediction of Atrial FibrillationCirculation · 2025
- Metabolic Status and Atrioventricular Block Risk: The Role of Physical ActivityReviews in Cardiovascular Medicine · 2025
- Artificial intelligence-estimated electrocardiographic sex as a recurrence predictor after atrial fibrillation catheter ablationEuropean Heart Journal - Digital Health · 2025
- Integration of Left Atrial Function Assessment, Genetic Risk, and Clinical Risk Factors Improves Prediction of Incident Atrial FibrillationJournal of the American Heart Association · 2025
- Pathogenic KCNH2-G53S variant in the PAS domain influences the electrophysiological phenotype in long QT syndrome type 2Frontiers in Cardiovascular Medicine · 2025